Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 9:14:1072288.
doi: 10.3389/fendo.2023.1072288. eCollection 2023.

The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study

Affiliations

The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study

Khalid Siddiqui et al. Front Endocrinol (Lausanne). .

Abstract

Objective: Chronic hyperglycemia induces pathogenic changes in the vascular endothelium and leads to the development of microvascular complications in patients with type 2 diabetes mellitus. Early identification of markers of diabetes complications may help to minimize the risk of the development and progression of microvascular complications.

Methods: This follow-up study was conducted in type 2 diabetic cohort aged between 30-70 years. Out of 160 eligible participants, 70 of them completed follow-up. Levels of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin and P-selectin) at baseline and follow-up were measured using Randox Evidence biochip analyzer (UK). Development of microvascular complications (diabetic neuropathy, retinopathy and nephropathy) was evaluated.

Results: During the follow-up (2 years, median), 31 (44.3%) developed diabetic neuropathy, 10 (14.3%) developed diabetic retinopathy and, 27 (38.6%) developed diabetic nephropathy. A significant difference in levels of cell adhesion molecules and selectins were found in type 2 diabetic patients with and without microvascular complications. Multiple logistic regression analysis reveals that baseline level of VCAM-1 is significantly associated with microvascular complications; diabetic neuropathy(p=0.028), retinopathy (p=0.007) and nephropathy(p=<0.001). Additionally, levels of P-selectin (p=0.05) and L-selectin (p=0.008) is associated with diabetic nephropathy while retinopathy associated with L-selectin (p=0.005) only.

Conclusion: Cell adhesion molecules and selectins are indicators of microvascular complication among patients with type 2 diabetes (T2D). Association of these markers with the development of microvascular complications may provide additive information for developing strategies for diabetes management and prediction of microvascular complications.

Keywords: adhesion molecule; complications; diabetic nephropathy; diabetic neuropathy; diabetic retinopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Shows the selection and recruitment of participants.
Figure 2
Figure 2
Shows the percentage of distribution of microvascular complications among type 2 diabetic patients at baseline (N=162) and follow-up (N=70). Dark color shows the “presence” and light color shows “absence” of corresponding complication.
Figure 3
Figure 3
(A) shows the percentage distribution of microvascular complications in quartiles of HbA1c and (B) shows the percentage distribution of microvascular complications in different groups of DM duration (years) at baseline (N=162) and follow-up (N=70). Dark color shows the “presence” and light color shows “absence” of corresponding complication. DM duration (diabetes mellitus duration), DN (diabetic nephropathy), DR (diabetic retinopathy), D Neu (diabetic neuropathy). P value <0.05 is statistically significant.

Similar articles

Cited by

References

    1. International Diabetes Federation . IDF diabetes atlas, 9th ed international diabetes federation, Brussels (2019). Available at: http://www.diabetesatlas.org (Accessed July 8, 2021).
    1. Chalmers J, Cooper ME. UKPDS and the legacy effect. N Engl J Med (2008) 359:1618–20. doi: 10.1056/NEJMe0807625 - DOI - PubMed
    1. Zoungas S, Arima H, Gerstein HC, Holman RR, Woodward M, Reaven P, et al. . Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: A meta-analysis of individual participant data from randomised controlled trials. Lancet Diabetes Endocrinol (2017) 5:431–7. doi: 10.1016/S2213-8587(17)30104-3 - DOI - PubMed
    1. Teodoro JS, Nunes S, Rolo AP, Reis F, Palmeira CM. Therapeutic options targeting oxidative stress, mitochondrial dysfunction and inflammation to hinder the progression of vascular complications of diabetes. Front Physiol (2019) 9:1857. doi: 10.3389/fphys.2018.01857 - DOI - PMC - PubMed
    1. American Diabetes Association . Diagnosis and classification of diabetes mellitus. Diabetes Care (2014) 37(1):S81–90. doi: 10.2337/dc14-S081 - DOI - PubMed

Publication types